Pathogenic Germline Variants in Uveal Melanoma Driver and BAP1 ‐Associated Genes in Finnish Patients with Uveal Melanoma
Pigment Cell & Melanoma Research · 2025
DOI: 10.1111/pcmr.13198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pigment Cell & Melanoma Research, 2025. Verfasst von Pauliina E Repo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Eye Genetics Group, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Uveal Neoplasms, Melanoma, Germ-Line Mutation, Ubiquitin Thiolesterase. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helsinki University Hospital Research Fund, Silmä- ja kudospankkisäätiö, Mary och Georg C. Ehrnrooths Stiftelse.
Abstract (Originalsprache)
Uveal melanoma (UM) is a rare yet aggressive eye cancer causing over 50% mortality from metastasis. Familial UM, amounting to 1%–6% of patients in Finland and the United States, mostly lack identified genetic cause, while 8% show associations with other cancer syndromes. We searched novel genetic associations for predisposition to UM, additional to already studied BAP1 and MBD4 , by using targeted amplicon sequencing of 19 genes associated with UM, BAP1, or renal cell carcinoma in 270 consecutively enrolled Finnish patients with UM. Key UM drivers GNAQ , GNA11 , CYSLTR2 , PLCB4 , EIF1AX , and SF3B1 lacked pathogenic germline variants. One patient carried the pathogenic BRCA1 variant c.3626del p.(Leu1209*), and one harbored a novel truncating MET variant c.252C > G p.(Tyr84*), classified as likely pathogenic. FLCN and BRCA2 , previously identified with pathogenic variants in patients with UM, did not have such variants in our cohort. Two patients were heterozygous for a pathogenic recessive BLM variant c.2824‐2A > T. None of the carriers of identified variants had familial UM. We identified BRCA1 and MET as genes with pathogenic germline variants in Finnish UM patients, each with a frequency of 0.4% (95% confidence interval, 0–2).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eye Genetics Group, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland.
- Ocular Oncology Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- Department of Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- Ophthalmic Genetics and Rare eye Diseases Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
ORCID-Profile: Pauliina E Repo, Tero T Kivelä
Förderung
- Helsinki University Hospital Research Fund
- Silmä- ja kudospankkisäätiö
- Mary och Georg C. Ehrnrooths Stiftelse
- Evald ja Hilda Nissin Säätiö
- Silmäsäätiö
- Syöpäsäätiö
Zitieren
APA
Repo, P. E., Jakkula, E., Hiltunen, J., Putkuri, H., Staskiewicz-Tuikkanen, A., Järvinen, R. S., Täll, M., Raivio, V., Al-Jamal, R. T., Kivelä, T. T., & Turunen, J. A. (2025). Pathogenic Germline Variants in Uveal Melanoma Driver and BAP1 ‐Associated Genes in Finnish Patients with Uveal Melanoma. Pigment Cell & Melanoma Research. https://doi.org/10.1111/pcmr.13198
Vancouver
Repo PE, Jakkula E, Hiltunen J, Putkuri H, Staskiewicz-Tuikkanen A, Järvinen RS, et al. Pathogenic Germline Variants in Uveal Melanoma Driver and BAP1 ‐Associated Genes in Finnish Patients with Uveal Melanoma. Pigment Cell & Melanoma Research. 2025. doi:10.1111/pcmr.13198
BibTeX
@article{Repo2025,
author = {Repo, Pauliina E and Jakkula, Eveliina and Hiltunen, Juho and Putkuri, Heidi and Staskiewicz-Tuikkanen, Aleksandra and Järvinen, Reetta-Stiina and Täll, Martin and Raivio, Virpi and Al-Jamal, Rana'a T and Kivelä, Tero T and Turunen, Joni A},
title = {Pathogenic Germline Variants in Uveal Melanoma Driver and BAP1 ‐Associated Genes in Finnish Patients with Uveal Melanoma},
journal = {Pigment Cell & Melanoma Research},
year = {2025},
doi = {10.1111/pcmr.13198}
}
EUVIMED